On April 22nd, at World Orphan Drug Congress USA Mapi will be leading a 4-hour workshop offering insight into
Overcoming challenges in Rare Disease Health Research and Orphan Drug Program commercialization.
Presenters include:
-
Kelly Franchetti,
RN, CCRN, CEN, Executive Director, Global Patients Insights and Engagement
-
Carla Dias-Barbosa,
MSc, Associate Research Director, Mapi HEOR & Strategic Market Access
-
Charles Makin,
BSPharm, MS, MBA, MM, Vice President, HEOR and Strategic Market Access
-
Ron Christensen,
MD, Chief Medical Officer
-
Patricia Anderson,
Vice President, Regulatory Services
Topics include:
-
The Process of Understanding the Person with the Indication
-
Patient Reported Outcomes Strategy
-
Market Access Challenges for Rare Diseases
-
Orphan Drug and Rare Diseases - Requirements for Real World Data
-
Regulatory Hurdles Orphan Drug - Are They Increasing
Download the workshop brochure to find out more about what Mapi will be discussing.